肝脏疾病中的自噬与能量代谢

摘要/Abstract

摘要： 肝脏疾病是危害全球千万人健康的常见病,其防治无论是在我国还是全球范围内的形势都依然严峻。自噬是维持机体稳态的重要生理过程,在众多肝脏疾病中有十分重要的作用。自噬可以通过直接或间接作用对能量代谢造成一定的影响,本文主要总结了肝脏疾病中自噬与能量代谢的联系,希望可以从自噬及代谢的角度为肝脏疾病的防治开辟有意义的方向。

张璐懿, 龚作炯. 肝脏疾病中的自噬与能量代谢[J]. 肝脏, 2022, 27(1): 12-14.

[1] Xiao J, Wang F, Wong N K, et al. Global liver disease burdens and research trends: Analysis from a Chinese perspective. J Hepatol, 2019, 71: 212-221.
[2] Yan S, Huda N, Khambu B, et al. Relevance of autophagy to fatty liver diseases and potential therapeutic applications. Amino Acids, 2017, 49: 1965-1979.
[3] Ueno T, Komatsu M. Autophagy in the liver: functions in health and disease. Nat Rev Gastroenterol Hepatol, 2017, 14: 170-184.
[4] Onishi M, Yamano K, Sato M, et al. Molecular mechanisms and physiological functions of mitophagy. Embo J, 2021, 40: e104705.
[5] Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol, 2018, 19: 349-364.
[6] Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol, 2011, 13: 132-141.
[7] Mizushima N, Levine B. Autophagy in Human Diseases. N Engl J Med, 2020, 383: 1564-1576.
[8] Seitz HK, Bataller R, Cortez-Pinto H, et al. Alcoholic liver disease. Nat Rev Dis Primers,2018, 4: 16.
[9] Williams JA, Ding WX. Role of autophagy in alcohol and drug-induced liver injury. Food Chem Toxicol, 2020, 136: 111075.
[10] Menk M, Graw JA, Poyraz D, et al. Chronic Alcohol Consumption Inhibits Autophagy and Promotes Apoptosis in the Liver. Int J Med Sci, 2018, 15: 682-688.
[11] Chao X, Ni HM, Ding WX. Insufficient autophagy: a novel autophagic flux scenario uncovered by impaired liver TFEB-mediated lysosomal biogenesis from chronic alcohol-drinking mice. Autophagy, 2018, 14: 1646-1648.
[12] Babuta M, Furi I, Bala S, et al. Dysregulated Autophagy and Lysosome Function Are Linked to Exosome Production by Micro-RNA 155 in Alcoholic Liver Disease. Hepatology, 2019, 70: 2123-2141.
[13] Liu L, Xie P, Li W, et al. Augmenter of Liver Regeneration Protects against Ethanol-Induced Acute Liver Injury by Promoting Autophagy. Am J Pathol, 2019, 189: 552-567.
[14] 全敏, 段英, 邢卉春. 酒精性脂肪性肝病与细胞自噬研究进展. 中国肝脏病杂志(电子版), 2021, 13: 25-29.
[15] Schott MB, Weller SG, Schulze RJ, et al. Lipid droplet size directs lipolysis and lipophagy catabolism in hepatocytes. J Cell Biol, 2019, 218: 3320-3335.
[16] Younossi Z, Tacke F, Arrese M, et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology, 2019, 69: 2672-2682.
[17] Martinez-Lopez N, Singh R. Autophagy and Lipid Droplets in the Liver. Annu Rev Nutr, 2015, 35: 215-237.
[18] Gao Y, Zhang W, Zeng LQ, et al. Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy. Redox Biol, 2020, 36: 101635.
[19] Wu WKK, Zhang L, Chan MTV. Autophagy, NAFLD and NAFLD-Related HCC. Adv Exp Med Biol, 2018, 1061: 127-138.
[20] Ma X, Mckeen T, Zhang J, et al. Role and Mechanisms of Mitophagy in Liver Diseases. Cells, 2020, 9:837.?.
[21] Wang L, Liu X, Nie J, et al. ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. Hepatology, 2015, 61: 486-496.
[22] Li R, Xin T, Li D, et al. Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy. Redox Biol, 2018, 18:229-243.
[23] Satriano L, Lewinska M, Rodrigues PM, et al. Metabolic rearrangements in primary liver cancers: cause and consequences. Nat Rev Gastroenterol Hepatol, 2019, 16: 748-766.
[24] Kimmelman AC, White E. Autophagy and Tumor Metabolism. Cell Metab, 2017, 25: 1037-1043.
[25] Jiao L, Zhang HL, Li DD, et al. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). Autophagy, 2018, 14: 671-684.
[26] Huang X, Gan G, Wang X, et al. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance. Autophagy, 2019, 15: 1258-1279.
[27] Stravitz RT, Lee WM. Acute liver failure. Lancet, 2019, 394: 869-881.
[28] Allaire M, Rautou PE, Codogno P, et al. Autophagy in liver diseases: Time for translation?. J Hepatol, 2019, 70: 985-998.
[29] Hernaez R, Solà E, Moreau R, et al. Acute-on-chronic liver failure: an update. Gut, 2017, 66: 541-553.
[30] Xue R, Yang J, Jia L, et al. Mitofusin2, as a Protective Target in the Liver, Controls the Balance of Apoptosis and Autophagy in Acute-on-Chronic Liver Failure. Front Pharmacol, 2019, 10: 601.
[31] Yu Z, Li J, Ren Z, et al. Switching from Fatty Acid Oxidation to Glycolysis Improves the Outcome of Acute-On-Chronic Liver Failure. Adv Sci (Weinh), 2020, 7: 1902996.

肝脏疾病中的自噬与能量代谢

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

本文评价

[1]	李娇娇, 师豆豆, 黄启超, 陶梅. 长链脂酰辅酶A合成酶1在肝癌中的表达及临床意义[J]. 肝脏, 2022, 27(1): 81-85.
[2]	陈崇高, 符厚萱, 王小智, 谢会忠. Beclin1及miRNA-130a与HBV相关慢加急性肝衰竭患者预后的相关性[J]. 肝脏, 2021, 26(2): 125-127.
[3]	刘晓岗, 沈预程, 刘春桂, 吉浩明. 沉默USP9X对肝癌HepG2细胞周期和自噬的作用机制[J]. 肝脏, 2020, 25(8): 888-890.
[4]	马向明, 侯婧悦, 付庆江, 曹立瀛. 线粒体丙酮酸载体在肝细胞癌中的表达及临床意义[J]. 肝脏, 2020, 25(6): 573-577.
[5]	张宁萍, 方颖, 刘雪静, 谢黎, 吴健, 沈锡中. N-乙酰半胱氨酸对非酒精性脂肪性肝炎模型小鼠肝细胞线粒体自噬的影响[J]. 肝脏, 2020, 25(4): 382-386.
[6]	马颖, 马玲, 马明. SIRT1通过增强分子伴侣介导的自噬降低细胞内脂质堆积改善非酒精性脂肪肝[J]. 肝脏, 2020, 25(12): 1320-1322.
[7]	孙丽杰, 施宇光, 张晓宇, 舒梦妮, 陈墨洋, 于建武. 丙型肝炎病毒核心蛋白活化内源性大麻素系统诱导不完全线粒体自噬[J]. 肝脏, 2018, 23(8): 673-675.
[8]	余思邈,朱云,高含佳,杜宁,王立福,孙永强,景婧,王丽苹,张帆,王睿林. 精神心理障碍在肝病科住院患者中的现况研究[J]. 肝脏, 2017, 22(11): 1017-1020.
[9]	孙丽杰,施宇光,张晓宇,舒梦妮,陈墨洋,于建武. 脂滴自噬在丙型肝炎病毒核心蛋白下调沉默信息调节因子1诱导小鼠肝脂肪变性中的作用[J]. 肝脏, 2017, 22(10): 891-893.
[10]	张巍, 邵明亮, 刘素芬, 陈翠英. 非酒精性脂肪肝自噬基因Beclin-1与核因子NF-κBp65表达研究[J]. 肝脏, 2017, 22(1): 20-.
[11]	满冬亮, 王齐晖. 不同肝脏疾病血清GP73、AFP-L3、AFP及AFU水平的表达[J]. 肝脏, 2016, 21(5): 368-371.